UMIN-CTR History
Name： UMIN ID：
| Unique ID issued by UMIN | UMIN000002692 |
|---|---|
| Receipt number | R000003280 |
| Scientific Title | A Phase II Study of Erlotinib for previously treated Non-small cell Lung Cancer Patients without Epidermal Growth Factor Receptor Mutation |
| Date of disclosure of the study information | 2009/11/01 |
| Last modified on | 2014/10/30 16:09:01 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2009/10/30 09:41:06 | ||
| 2 | Update | 2011/02/17 19:09:39 | Recruitment status |
|
| 3 | Update | 2011/05/30 21:23:35 | Name of person sending information Organization Division name Address Organization Organization Category of Funding Organization Nationality of Funding Organization Nationality of Funding Organization |
|
| 4 | Update | 2012/05/13 10:27:52 | Co-sponsor Co-sponsor Post marketing survey by drug manufacture etc., specified by Japanese law. |
|
| 5 | Update | 2012/05/13 10:29:35 | Recruitment status |
|
| 6 | Update | 2014/10/30 16:07:21 | Recruitment status Publication of results |
|
| 7 | Update | 2014/10/30 16:09:01 | Email |
